Cigna

Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023.Victoria Klesty | ReutersCigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and employers spend on the highly popular treatments each year. The move comes as many insurers mull whether they should cover those drugs or drop them from their plans altogether due to their high costs. Americans have flocked to the treatments, along…

The deal is expected to close in early 2025 if antitrust authorities and other regulators sign off.  The deal is expected to close in early 2025 if antitrust authorities and other regulators sign off.  FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the…

Sopa Images | Lightrocket | Getty ImagesShares of Cigna jumped Monday following reports that the health-care giant has scrapped its plans to buy rival Humana due to disagreements on price, putting an early end to what would have been one of the largest deals of the decade.Cigna late Sunday also announced plans to buy back $10 billion worth of shares, bringing its total planned repurchases to $11.3 billion. The company said in a release that it will consider smaller, "bolt-on" acquisitions in the near term, but did not…

The Cigna Group headquarters in Bloomfield, Connecticut, US, on Friday, Oct. 27, 2023. BlooJoe Buglewicz | Bloomberg | Getty ImagesShares of Cigna slid on Wednesday after a report that the company is in talks with Humana about a merger between the two health care giants. Spokespeople for Cigna and Humana did not immediately respond to requests for comment on the report from the Wall Street Journal, which cited people familiar with the matter. The companies are discussing a stock-and-cash deal that could be finalized by…

Last year, Elon Musk changed Twitter’s verified program from a quasi-signal that a user is notable to a pay-for-checkmark $8 free-for-all. Immediately, trolls and comedians seized on the opportunity, making verified fake accounts for politicians, reminding people of Chiquita Banana’s involvement in genocide, and arranging a pretend, but disgusting, conversation between Ben Shapiro and Ted Cruz.The most significant fallout, though, came with a tweet from a user pretending to be drug manufacturer Eli Lily. After the user…

Starting next year the highest-grossing drug of all time, AbbVie ABBV 0.14% ‘s Humira, will finally face competition from copycat biologics in the U.S. Yet the makers of the complex generics known as biosimilars won’t necessarily be the biggest winners. The top beneficiaries could instead be the middlemen such as Cigna CI 1.27% and CVS Health, CVS…

A unit of Walgreens Boots Alliance Inc. WBA 3.72% is nearing a deal to combine with a big owner of medical practices and urgent-care centers in a transaction worth roughly $9 billion including debt, according to people familiar with the matter, the latest in a string of acquisitions by big consumer-focused companies aiming to delve deeper into medical care. The drugstore giant’s primary-care-center subsidiary, Village Practice…

Insurers and employers began publicly posting the prices they pay for healthcare services ranging from doctor visits to lab tests, hugely expanding a federally mandated effort to unveil the long-secret rates.The new data is coming in the form of massive, machine-readable digital files, typically in formats not easily accessible to consumers, posted mostly on insurers’ websites. The Centers for Medicare and Medicaid Services set a deadline of July 1 for the data to be released, with some big insurers releasing data by the…

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/after-roe-v-wade-ruling-companies-reimbursing-medical-and-travel-expenses-for-abortion-risk-blowback-11656109337 This copy is for your personal, non-commercial use only. Distribution and use of this…

Check out the companies making headlines before the bell:Under Armour (UAA) – The athletic apparel maker posted an adjusted loss of 1 cent per share in the company's transition quarter, compared with a profit estimate of 6 cents per share. The company is changing its fiscal year, with the first quarter of fiscal 2023 beginning April 1. Under Armour also issued a weaker-than-expected outlook for its full-year profit as it absorbs the impact of higher costs and supply chain disruptions. Under Armour plunged 12.5% in…